Atlas Trials

ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Clinical trial NCT00014690 · COMPLETED

Trial details

NCT number
NCT00014690
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Start date
2001-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.